|
MICHAEL DOUGAN, M.D., PhD. |
Dr. Michael Dougan is currently an Assistant Professor of Medicine at Massachusetts General Hospital and Harvard Medical School and serves as Director of the Immunotherapy Mucosal Toxicities Program at Massachusetts General Hospital. He received an M.D. and a Ph.D. from Harvard Medical School, completing his dissertation work in Immunology with the renowned Glenn Dranoff, M.D., at the Dana-Farber Cancer Institute where he studied the interplay between chronic inflammation, tumor promotion, and antitumor immunity. In 2017, Dr. Dougan completed an Internal Medicine residency and Gastroenterology fellowship at Massachusetts General Hospital. |